Risks are no longer confined to discrete areas and functions. From regulatory pressures to consumers demanding more transparency, organizations are increasingly seeking total solutions over point services. Additionally, evolving health care regulations require clearer views into product research and development, product launches, mergers and acquisitions, asset sales and other pharma transactions. Pharmaceutical companies must adapt their practices to protect their financial interests and remain competitive.
To minimize risks and meet compliance requirements, PwC works with your organization to address challenges posed by pharma industry trends such as:
PwC’s assurance practice helps solve complex business issues faced by management and boards, and serves the public interest by supporting the capital markets system through reliable financial reporting. By assembling a diverse team of professionals, we provide insight, advisory services, and independent assurance that enable informed business decisions and provide safeguards in today’s complex operating environment.
We help pharma companies:
More on our US Audit and Assurance practice
US Pharmaceutical & Life Sciences Assurance Leader, PwC US